Xylose - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for xylose and what is the scope of patent protection?
Xylose
is the generic ingredient in two branded drugs marketed by Savage Labs and Lyne, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for xylose.
Summary for xylose
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 4 |
Patent Applications: | 5,394 |
DailyMed Link: | xylose at DailyMed |
Recent Clinical Trials for xylose
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Indena S.p.A | Phase 2 |
Sintesi Research Srl | Phase 2 |
L'Oreal | N/A |
US Patents and Regulatory Information for xylose
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lyne | XYLOSE | xylose | POWDER;ORAL | 018856-001 | Mar 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Savage Labs | XYLO-PFAN | xylose | POWDER;ORAL | 017605-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |